icon
Treatments
Programmeicon
How it works
Treatments, coaching and habit change programme
Coaching
The support of a dedicated health coach
Voy app
Track your progress whilst creating healthy sustainable habits
Results
About
Experts
Resourcesicon
Guides & tips
Tools and tips for lasting weight loss
Research & science
Evidence-based insights and clinical research
icon
icon
menu-close
OVERVIEW
Treatments
icon
How it works
icon
Coaching
icon
Voy app
icon
EXPLORE
Results
icon
About
icon
Experts
icon
Resources
icon
ACCOUNT
Login
icon
GET IN TOUCH
020 3912 9885
Mon-Fri 9:00-17:30
icon
Guides & tips
icon
Research & science
icon
Home/Guides & Tips/Medications/

PCOS and Mounjaro

Mounjaro for PCOS: Can it help with symptoms?

If you have PCOS and struggle with weight loss, can you be prescribed Mounjaro? Let’s look at what studies say, benefits and side effects, plus a recommended weight management plan for using Mounjaro with PCOS.

clinician image

Medically reviewed by

Dr Earim Chaudry (MBBS), Chief Medical Officer

iconUpdated 23rd May 2024
Research-Based Guide
Table of contents
  • What is PCOS?
  • How does Mounjaro help PCOS?
  • Other potential benefits of Mo...
  • How long do you need to take M...
  • Mounjaro and PCOS: Potential s...
  • Can Mounjaro be prescribed for...
  • Starting a weight management p...
  • Your PCOS and weight loss jour...

Managing your weight while juggling other PCOS symptoms like irregular periods and excess body hair can feel overwhelming. If your PCOS is causing you to struggle with your weight, you're not alone, and there are new treatment options that may help, such as Mounjaro (tirzepatide), a type of medication originally developed to treat type 2 diabetes, now commonly prescribed for weight loss.

In this article, we'll explain how Mounjaro may help with PCOS, the science behind its effects, and how it could fit into a wider plan for managing symptoms and improving overall health.

What is PCOS?

PCOS is a condition that is caused by imbalance of reproductive hormones. It affects one in 10 women of childbearing age and includes symptoms like:

  • Irregular periods or no periods at all
  • Hair growth
  • Hair thinning or loss
  • Weight gain
  • Acne or oily skin
  • Trouble getting pregnant

Not everyone will have the same symptoms, or experience them in the same severity. To be diagnosed with PCOS, you need to meet two out of three of these conditions:

  • Irregular periods
  • Blood tests indicating high levels of androgens—sex hormones generally associated with men
  • Polycystic ovaries—you’d know this via an ultrasound scan showing enlarged ovaries and fluid-filled sacs (follicles) surrounding the eggs

We still don’t know what actually causes PCOS. It’s often genetic, and it’s thought that hormonal imbalances, like an excess of androgens could be a main cause. Androgens can prevent the ovaries from ovulating (releasing an egg) and cause hair growth, acne, and increased appetite.

It may also be down to high levels of insulin, a hormone that regulates and controls the body’s sugar levels (glucose). Lots of people with PCOS are ‘insulin resistant’, meaning their bodies don’t react as they should to insulin, so they produce higher levels of insulin to try and overcome it.

Being overweight can increase the amount of insulin your body produces, so losing weight can better regulate your blood sugar levels. But insulin resistance makes it hard to lose weight because the body stores excess blood sugar as fat. Seems like a never ending cycle, right?

That’s where Mounjaro comes in.

Discover Mounjaro
Ready to take the next step in your weight loss journey? Learn more about Mounjaro and how Voy’s new approach to weight management could help you meet your health goals.
icon
Science backed programme
icon
Personalised support
icon
Trusted by 100,000+ UK customers

How does Mounjaro help PCOS?

So you’re probably wondering, “is Mounjaro good for PCOS”? It might be. Mounjaro doesn’t specifically treat PCOS, but the weight loss gained from Mounjaro can help improve your PCOS symptoms. Insulin resistance is also a main symptom of type 2 diabetes. Mounjaro was originally developed as a drug to treat type 2 diabetes to manage glucose control, and now research has developed to suggest that Mounjaro can also help some people with PCOS and it's safe for weight loss as well.

Normally when we eat, natural hormones called GIP and GLP-1 are released by our gut. The active ingredient in Mounjaro, tirzepatide, mimics these natural hormones by activating the GIP and GLP-1 receptors. Mounjaro can help to suppress your appetite by slowing digestion and making you feel fuller for longer, reducing hunger and cravings.

Mounjaro for PCOS weight loss

Weight gain is a common symptom of PCOS, which increases the likelihood of developing other conditions like type 2 diabetes. Weight gain can also impact how regularly you have a period or ovulate — in some cases, people with PCOS might not ovulate at all (called anovulation).

This is why weight loss is often recommended as a first-line treatment—even a modest weight loss of 5% of body weight has been shown in studies to significantly improve PCOS symptoms, including restoring more regular menstrual cycles, improving ovulation, reducing androgen levels (which cause symptoms like acne and excess hair growth), and lowering the risk of developing type 2 diabetes and heart disease.

However, achieving and maintaining weight loss with PCOS can be particularly challenging. This is where Mounjaro (tirzepatide) may offer valuable support. Mounjaro can aid in weight loss by:

  • Slowing down digestion, which helps you feel fuller for longer and reduces the urge to overeat
  • Suppressing appetite and cravings by mimicking gut hormones involved in regulating hunger
  • Improving blood sugar control, which reduces insulin spikes that can otherwise promote fat storage and weight gain

By helping to address some of the metabolic drivers of weight gain in PCOS, Mounjaro can facilitate the kind of sustainable weight loss that leads to meaningful improvements in reproductive health, hormonal balance, and overall wellbeing.

Mounjaro for insulin resistance in PCOS

As we mentioned earlier, insulin resistance affects a large proportion of those with PCOS. Mounjaro helps improve insulin sensitivity, which could improve PCOS symptoms such as skin issues and menstrual irregularities.

Mounjaro for fertility in PCOS

PCOS can cause irregular ovulation or even anovulation (lack of ovulation), making it harder to conceive. Carrying excess weight and having a higher BMI can also negatively impact fertility, further disrupt hormonal balance, and cause irregular cycles.

If you’re hoping to have a baby in the future, Mounjaro might have the added benefit of helping you fall pregnant more easily. By promoting weight loss and improving insulin sensitivity, Mounjaro can result in secondary benefits such as helping restore ovulation, leading to more regular periods and potentially improved fertility. It’s important to note that you must stop Mounjaro at least 1 month before trying to conceive.

On the flip side, if you’re trying to avoid pregnancy, using Mounjaro can actually make your contraceptive pill less effective. So you will need to use another non-oral contraception method, like the IUD or condoms. If you are pregnant, you should not use Mounjaro.

Other potential benefits of Mounjaro for PCOS

There are limited studies on the direct benefits of Mounjaro for PCOS, and while the randomised control trials that have been conducted for similar medications have shown that these drugs do have a positive impact on weight loss, the studies were small. Further research into managing obesity in PCOS specifically is needed.

But the benefits of Mounjaro for PCOS could include:

  • Weight loss
  • Reduced cravings
  • Better insulin sensitivity
  • Reduced inflammation
  • Better heart health
  • Improved self esteem
Struggling to lose weight with PCOS?
Women with PCOS that use the Voy app can expect to lose 85% more weight than women that don’t.

How long do you need to take Mounjaro to see results?

Other weight loss drugs, like Wegovy, also work in the same way to mimic the hormone GLP-1. But because tirzepatide mimics two hormones instead of one, it’s more potent than other weight loss medications. One study showed greater weight loss by participants taking tirzepatide over semaglutide. But weight loss medications aren’t a short-term solution. They’re meant to supplement healthy lifestyle changes, and for best results, most people will need to take them for over a year.

Mounjaro starts working immediately, but it can take a few weeks before you notice your appetite reducing or any significant weight loss. You’ll start on the lowest dose, but some people may need higher doses to get the best results, and that's completely normal too. Your Voy coach and clinical team will help you find the right dose for your weight loss goal.

Mounjaro and PCOS: Potential side effects

You might be wondering “is Mounjaro safe for PCOS?”. Like all medications, Mounjaro can come with side effects. So it’s important to familiarise yourself with these before you start your treatment journey. In most cases, Mounjaro side effects are mild and manageable. They can include gut-related symptoms like diarrhoea, nausea, burping and constipation.

Side effects support at Voy

"If you're using Voy and you experience any side effects, rest assured that our expert clinicians are just a message or phone call away. They can adjust your dose, prescribe medication to ease your symptoms, or simply offer reassurance.

Everyone responds differently to weight loss treatment and we'll help you find what feels right for you."

Phoebe Fox - Weight Loss Specialist Clinician

Can Mounjaro be prescribed for PCOS in the UK?

While Mounjaro isn't specifically approved for PCOS, it might help with weight management, which can often be challenging if you have the condition. Mounjaro isn't currently prescribed on the NHS, so you'll need to seek out a private medical service to secure a prescription. To be prescribed Mounjaro for weight loss, if you have a diagnosis of PCOS, you’ll need to have a BMI of 27 or more. If you’re already at a healthy BMI, you won’t be able to use Mounjaro.

It’s important to consult a medical professional before using Mounjaro to understand the side effects as well as benefits. This is especially true if you are taking any other medications, as it could make them less effective. Good news for those who already take metformin, as you can take it alongside Mounjaro with no issues.

Starting a weight management plan for Mounjaro with PCOS

Losing just 5% of your body weight can lead to a noticeable improvement in PCOS symptoms. One clinical trial showed that patients taking 10mg of tirzepatide lost 17% of their body weight on average during the 72-week study, while patients taking 5mg of tirzepatide lost 15%. However, for long-lasting weight loss, building a healthy relationship with food and exercise alongside Mounjaro is essential.

Not sure where to start? Voy’s personalised programme combines clinically proven medication and lifestyle coaching to help you achieve your weight loss goals and stick to them.

Your PCOS and weight loss journey

We know the hours of research that go into finding a new medication to help manage a medical condition. It’s long, often confusing, and can feel like a gamble when there’s money involved. Choosing a weight loss programme comes down to your personal needs and preferences. But here’s how Voy compares to other providers, if you’re wondering.

If you’ve tried countless diets and exercise routines that just haven’t worked how you’d have liked, weight loss injections like Mounjaro might be a well-suited next step of your PCOS symptom management. To find out if our weight loss programme is for you, take a few minutes to fill out this short quiz, and our team of experts will be in touch with personalised advice to help you reach your goals.

FAQ

Mounjaro and PCOS: FAQ

Dr Earim Chaudry, MBBS
DisclaimerAt Voy, we ensure that everything you read in our blog is medically reviewed and approved. However, the information provided is not meant to replace professional medical advice, diagnosis, or treatment. It should not be relied upon for specific medical advice.
References
icon¹

Al-Sabah, Suleiman. “Molecular Pharmacology of the Incretin Receptors.” Medical Principles and Practice: International Journal of the Kuwait University, Health Science Centrescribble-underline, vol. 25, suppl. 1, 2016, pp. 15–21, doi:10.1159/000433437.

icon²

Anala, Alekya Devi, et al. “The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome.” Journal of Clinical Medicinescribble-underline, vol. 12, no. 14, 10 July 2023, p. 4575, doi:10.3390/jcm12144575.

icon³

Balen, Adam H., and Anthony J. Rutherford. “Managing Anovulatory Infertility and Polycystic Ovary Syndrome.” BMJ (Clinical Research Edition)scribble-underline, vol. 335, no. 7621, 2007, pp. 663–66, doi:10.1136/bmj.39335.462303.80.

icon⁴

“Calculate Your Body Mass Index (BMI) for Adults.” NHSscribble-underline, 28 Nov. 2023, www.nhs.uk/health-assessment-tools/calculate-your-body-mass-index/calculate-bmi-for-adults. Accessed 20 Nov. 2024.

icon⁵

Kourtidou, Christodoula, and Konstantinos Tziomalos. “Pharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome.” Biomedicinesscribble-underline, vol. 11, no. 2, 8 Feb. 2023, p. 496, doi:10.3390/biomedicines11020496.

icon⁶

Lasquety, Mary Grace, et al. “The Influence of BMI Levels on Phases of the Menstrual Cycle and Presumed Ovulation.” The Linacre Quarterlyscribble-underline, vol. 79, no. 4, 2012, pp. 451–59, doi:10.1179/002436312804827082.

icon⁷

Lashen, Hany. “Role of Metformin in the Management of Polycystic Ovary Syndrome.” Therapeutic Advances in Endocrinology and Metabolismscribble-underline, vol. 1, no. 3, 2010, pp. 117–28, doi:10.1177/2042018810380215.

icon⁸

Medicines and Healthcare Products Regulatory Agency. “MHRA Authorises Diabetes Drug Mounjaro (Tirzepatide) for Weight Management and Weight Loss.” GOV.UKscribble-underline, 8 Nov. 2023, www.gov.uk/government/news/mhra-authorises-diabetes-drug-mounjaro-tirzepatide-for-weight-management-and-weight-loss. Accessed 20 Nov. 2024.

icon⁹

“Polycystic Ovary Syndrome.” NHSscribble-underline, 2022, www.nhs.uk/conditions/polycystic-ovary-syndrome-pcos/. Accessed 20 Nov. 2024.

icon¹⁰

“Polycystic Ovary Syndrome.” Office on Women’s Healthscribble-underline, 2021, www.womenshealth.gov/a-z-topics/polycystic-ovary-syndrome. Accessed 20 Nov. 2024.

icon¹¹

“Project Information: Tirzepatide for Managing Overweight and Obesity [ID6179]: Guidance.” NICEscribble-underline, National Institute for Health and Care Excellence, www.nice.org.uk/guidance/indevelopment/gid-ta11156. Accessed 20 Nov. 2024.

icon¹²

Rodriguez, P. J., et al. “Semaglutide vs Tirzepatide for Weight Loss in Adults with Overweight or Obesity.” JAMA Internal Medicinescribble-underline, vol. 184, no. 9, 2024, pp. 1056–64, doi:10.1001/jamainternmed.2024.2525.

icon¹³

Tall Bull, Shasta, et al. “Tirzepatide: A Novel, First-in-Class, Dual GIP/GLP-1 Receptor Agonist.” Journal of Diabetes and Its Complicationsscribble-underline, vol. 36, no. 12, Dec. 2022, p. 108332, doi:10.1016/j.jdiacomp.2022.108332.

icon¹⁴

“Tirzepatide.” NICEscribble-underline, National Institute for Health and Care Excellence, bnf.nice.org.uk/drugs/tirzepatide/#side-effects. Accessed 20 Nov. 2024.

icon¹⁵

“Tirzepatide: Uses, Dosage, Side Effects & Warnings.” Drugs.comscribble-underline, 12 Nov. 2024, www.drugs.com/tirzepatide.html. Accessed 20 Nov. 2024.

icon¹⁶

“What Is Mounjaro?” Diabetes UKscribble-underline, 4 Oct. 2024, www.diabetes.org.uk/about-diabetes/looking-after-diabetes/treatments/tablets-and-medication/glp-1/mounjaro. Accessed 20 Nov. 2024.

icon¹⁷

“What Is Zepbound | Zepbound (Tirzepatide).” Zepboundscribble-underline, zepbound.lilly.com/what-is-zepbound. Accessed 20 Nov. 2024.

icon¹⁸

Willard, Francis S., et al. “Tirzepatide Is an Imbalanced and Biased Dual GIP and GLP-1 Receptor Agonist.” JCI Insightscribble-underline, vol. 5, no. 17, 3 Sept. 2020, doi:10.1172/jci.insight.140532.

icon¹⁹

Zhao, Han, et al. “Insulin Resistance in Polycystic Ovary Syndrome Across Various Tissues: An Updated Review of Pathogenesis, Evaluation, and Treatment.” Journal of Ovarian Researchscribble-underline, vol. 16, no. 1, 11 Jan. 2023, p. 9, doi:10.1186/s13048-022-01091-0.

icon²⁰

Zhu, Lei, et al. “Association Between Body Mass Index and Female Infertility in the United States: Data from National Health and Nutrition Examination Survey 2013–2018.” International Journal of General Medicinescribble-underline, vol. 15, 19 Feb. 2022, pp. 1821–31, doi:10.2147/IJGM.S349874.

card-image
Medication
How long does it take for Mounjaro to suppress appetite?
Taking Mounjaro and still craving comfort foods? Here’s what might be going on.
card-image
Medication
What is Ozempic mouth?
Here we take a look at what’s being dubbed “Ozempic mouth” and whether it’s something you need to worry about.
card-image
Medication
Retatrutide, tirzepatide, or semaglutide?
Wondering how different weight loss medicines stack up? Here’s a head-to-head comparison of retatrutide vs tirzepatide vs semaglutide.
card-image
Medication
Retatrutide dosage guide
Retatrutide, a weekly weight loss injection, isn’t approved yet, but here’s what we know right now about the dosing schedule for this experimental treatment.
Have a question?
Whatever it is, get in touch:
message
020 3912 9885Mon-Fri 9:00-17:00
message
help@joinvoy.comWe aim to reply in 24hrs
Mon-Fri 9:00-17:00
We aim to reply in 24hrs
Our services are not intended for use in a medical emergency. If you need urgent medical attention, please call 111 or 999

PROGRAMME

  • How it works
  • Treatments
  • Coaching
  • The Voy app

VOY

  • Results
  • About
  • Our medical experts

HELP

  • Help Centre (FAQ)
logo
Privacy PolicyTerms & Conditions
Terms of SaleComplaints
Pharmacies: Manual Pharmacy
Superintendent Pharmacist
Vinisha Kanda
GPhC Registration: 2203475
Copyright 2025 Voy™. All rights reserved.
cards
pharmacy-contact
Privacy Preference Center
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below. The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.
Manage Consent Preferences
icon
Necessary Cookies
Always Active
Necessary cookies ensure the basic functionalities of the website, such as security, network management, and accessibility. These cookies cannot be disabled and do not store personal information.
icon
Preferences Cookies
Preferences cookies allow the website to remember information that changes the way the site behaves or looks, such as your preferred language or region.
icon
Statistics Cookies
Statistics cookies help us understand how visitors interact with the website by collecting and reporting information anonymously. These cookies provide insights into metrics such as page visits and traffic sources.
icon
Marketing Cookies
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and more valuable to publishers and third-party advertisers.